-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - outcomes including sleep
apnea, degenerative joint disease, diabetes, cardiovascular disease,
cancer, liver … • Cancer
• Cardiovascular disease
• Sub-fertility
• Diabetes
• Degenerative joint
disease
• Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - “limited”
Page 33, line 44: “which is the rate limiting step
for cholesterol synthesis in the liver … The Zieve article reported
similar AE incidence, but numerically greater
liver enzyme elevations and … There were 2 cases of
elevated liver enzymes with combination
therapy vs 1 with statin monotherapy. … considered possibly related to study treatment
(rash with monotherapy, and myalgia and
elevated liver
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Infection
Hepatitis C virus (HCV) is a major public health concern, the primary cause of death from liver … disease, and the leading cause for liver transplantation in the U.S. … who are prior
nonresponders to IFN-RBV with other comorbid conditions such as nonalcoholic fatty liver … do not achieve a sustained virologic
response (SVR) or viral cure, leaving them at risk for future liver … Effective treatment
could also reduce the long-term costs of complications such as cirrhosis and liver
-
effectivehealthcare.ahrq.gov/health-topics/spleen-diseases
-
effectivehealthcare.ahrq.gov/health-topics/hodgkin-disease
-
effectivehealthcare.ahrq.gov/health-topics/organ-donation
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - Horizon Scanning System
AHRQ Priority Area 11 – Peptic Ulcer Disease and Dyspepsia
such as liver … with SBS is 30%.
24
Long-term parenteral
nutrition (PN) can lead to serious side effects such as liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
January 30, 2012 - Food and Drug Administration; HAS-BLED =
hypertension, abnormal renal/liver function, stroke, bleeding … Food and Drug Administration
GWTG Get With The Guidelines
HAS-BLED hypertension, abnormal renal/liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - breast neoplasms/ or Colonic Neoplasms/ or exp Endocrine Gland Neoplasms/ or
Intestinal Neoplasms/ or liver … or liver or lung?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - breast neoplasms/ or Colonic Neoplasms/ or exp Endocrine Gland Neoplasms/ or
Intestinal Neoplasms/ or liver … or liver or lung?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - contraindicated with methadone or buprenorphine; history of methadone/buprenorphine maintenance; pregnant; liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
October 27, 2017 - The HAS-BLED (H=hypertension,
A=abnormal renal/liver function, S=stroke, B=bleeding history or predisposition … glomerular filtration rate;
ESRD = end-stage renal disease; HAS-BLED = hypertension, abnormal renal/liver … Evidence-based Practice Center
ESRD end-stage renal disease
HAS-BLED hypertension, abnormal renal/liver
-
effectivehealthcare.ahrq.gov/health-topics/reye-syndrome
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - Drug Class Mechanism Example Drugs
Biguanide Suppresses glucose production
by the liver
§ Metformin … L
iv
er
in
ju
ry
The risk of liver injury was similar for
thiazolidinediones and sulfonylureas. … The rates of liver injury were similar between
thiazolidinediones and metformin. … (Insufficient) New Evidence:
L
iv
er
in
ju
ry
The risk of liver injury was similar for thiazolidinediones … (High)
New Evidence:
The rates of liver injury were similar between thiazolidinediones and
metformin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
April 01, 2012 - 2
supports the use of MTX as the oral DMARD of choice
unless there are contraindications (e.g., liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - contraindicated with methadone or buprenorphine; history of methadone/buprenorphine maintenance; pregnant; liver
-
effectivehealthcare.ahrq.gov/health-topics/viral-infections
-
effectivehealthcare.ahrq.gov/health-topics/thalassemia
-
effectivehealthcare.ahrq.gov/health-topics/alcohol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
May 01, 2023 - preeclampsia with and without severe features, eclampsia (seizure), and HELLP
(hemolysis, elevated liver